HeyJaredEli Walsh
- Indexed articles, last 90 days
- 26
- Latest publication
- Sep 30, 2026
- Outlet visibility, for San Diego Business Journal
- Top 5M sites
- Earliest in this view
- Aug 10, 2026
Latest articles
Nuvve Launches AI-Powered Grid Demand Forecasting Platform (opens the original)
Read excerpt
SAN DIEGO – Renewable energy batteries are only as good as how intelligently their supply is deployed. According to the non-profit research and advocacy organization Institute for Local Self-Reliance, a 2019 investigation of electric energy forecasts from seven of the country’s 10 largest utilities found that the average forecast overestimated demand by nearly 20% over a three-year span. Grid modernization and electric vehicle charging tech company Nuvve Holding Corp. (Nasdaq: NVVE) is aiming to
Axiom Bio Pursuing IPO in Hong Kong (opens the original)
Read excerpt
BIOTECH: Pipeline Centered on Umbilical Cord-derived Stem Cells CARLSBAD – Axiom Biosciences is not limiting its opportunities. “If you could deliver one molecule to, let’s say, one tumor or one organ or one tissue type, and repeatedly show that you could do that,” Axiom founder and CEO Dr. Remo Moomiaie-Qajar said, “then the molecule becomes a second thought, because you deliver one, you could deliver 1,000.” Whereas most biopharmaceutical startups focus on shepherding one novel drug through di
Persephone Bio Synbiotic Giving Good Gut Feeling (opens the original)
Read excerpt
BIOTECH: Blend of Probiotics, Prebiotics Provides Essential Healthy Bacteria to Infants SAN DIEGO – Roughly 90% of babies in the U.S. are born without the essential levels of certain gut bacteria that they need to develop a robust immune system. Babies have historically been exposed to vital gut bacteria during the birthing process, which is often a messy experience for both baby and mother. However, that’s begun to change as modern medical practices have prioritized sterilization and cleanlines
Sentynl Watching Over Rare Disease Patients (opens the original)
Read excerpt
BIOPHARMA: Co. Handles Commercialization of Critical Drugs SOLANA BEACH – The thousands of distinct rare diseases that affect millions of people around the world all have one thing in common. “What unites many of these patients is a stark reality: significant unmet medical needs and limited treatment options,” stated Matt Heck, the CEO of Sentynl Therapeutics. “While their rarity makes them commercially unattractive to larger pharmaceutical companies, it doesn’t diminish clinical urgency.” Senty
VedaBio Bringing Molecular Diagnostics Platform to Urgent Care (opens the original)
Read excerpt
DIAGNOSTICS: Startup Inks Partnership to Speed Adoption SAN DIEGO – For many Americans, urgent care has become the place they receive primary care services. Around one-quarter of U.S. adults and nearly half of adults under age 30 don’t have a primary care physician, according to the Kaiser Family Foundation. Concurrently, the number of urgent care clinics has nearly doubled, from 7,000 in 2014 to more than 15,000 in 2024, according to the Urgent Care Association. Around one-third of the 200 mill
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For San Diego Business Journal, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.